151 related articles for article (PubMed ID: 33991675)
1. Improving the yield of recalcitrant Nanobodies® by simple modifications to the standard protocol.
Kariuki CK; Magez S
Protein Expr Purif; 2021 Sep; 185():105906. PubMed ID: 33991675
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic versus periplasmic expression of site-specifically and bioorthogonally functionalized nanobodies using expressed protein ligation.
Billen B; Vincke C; Hansen R; Devoogdt N; Muyldermans S; Adriaensens P; Guedens W
Protein Expr Purif; 2017 May; 133():25-34. PubMed ID: 28238765
[TBL] [Abstract][Full Text] [Related]
3. Camelid nanobodies used as crystallization chaperones for different constructs of PorM, a component of the type IX secretion system from Porphyromonas gingivalis.
Duhoo Y; Roche J; Trinh TTN; Desmyter A; Gaubert A; Kellenberger C; Cambillau C; Roussel A; Leone P
Acta Crystallogr F Struct Biol Commun; 2017 May; 73(Pt 5):286-293. PubMed ID: 28471361
[TBL] [Abstract][Full Text] [Related]
4. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein.
Salema V; Fernández LÁ
Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605
[TBL] [Abstract][Full Text] [Related]
5. Method for efficient soluble expression and purification of recombinant human interleukin-15.
Ahmed N; Afroze B; Abbas R; Khan MA; Akram M; Tahir S; Bakht S; Munir A; Shahid AA
Protein Expr Purif; 2021 Jan; 177():105746. PubMed ID: 32916300
[TBL] [Abstract][Full Text] [Related]
6. Nanobody production can be simplified by direct secretion from Escherichia coli.
Iwaki T; Hara K; Umemura K
Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic and periplasmic expression of recombinant shark VNAR antibody in Escherichia coli.
Leow HC; Fischer K; Leow YC; Braet K; Cheng Q; McCarthy J
Prep Biochem Biotechnol; 2019; 49(4):315-327. PubMed ID: 30767708
[TBL] [Abstract][Full Text] [Related]
8. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
[TBL] [Abstract][Full Text] [Related]
9. Secretory production of a camelid single-domain antibody (VHH, nanobody) by the Serratia marcescens Lip system in Escherichia coli.
Asada T; Takagi D; Nakai M; Abe S; Yuasa K
Biochem Biophys Res Commun; 2021 Apr; 549():105-112. PubMed ID: 33667707
[TBL] [Abstract][Full Text] [Related]
10. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Periplasmic Expression in Escherichia coli for the Production of Recombinant Proteins Tagged with the Small Metal-Binding Protein SmbP.
Santos BD; Morones-Ramirez JR; Balderas-Renteria I; Casillas-Vega NG; Galbraith DW; Zarate X
Mol Biotechnol; 2019 Jun; 61(6):451-460. PubMed ID: 30997666
[TBL] [Abstract][Full Text] [Related]
12. Expression of single-domain antibodies in bacterial systems.
Baral TN; Arbabi-Ghahroudi M
Methods Mol Biol; 2012; 911():257-75. PubMed ID: 22886257
[TBL] [Abstract][Full Text] [Related]
13. Generation of Nanobodies against SlyD and development of tools to eliminate this bacterial contaminant from recombinant proteins.
Hu Y; Romão E; Vertommen D; Vincke C; Morales-Yánez F; Gutiérrez C; Liu C; Muyldermans S
Protein Expr Purif; 2017 Sep; 137():64-76. PubMed ID: 28668496
[TBL] [Abstract][Full Text] [Related]
14. Production and Application of Nanobodies for Membrane Protein Structural Biology.
Brunner JD; Schenck S
Methods Mol Biol; 2020; 2127():167-184. PubMed ID: 32112322
[TBL] [Abstract][Full Text] [Related]
15. Efficient expression, purification and characterization of native human cystatin C in Escherichia coli periplasm.
Zhou Y; Zhou Y; Li J; Chen J; Yao Y; Yu L; Peng D; Wang M; Su D; He Y; Gou L
Protein Expr Purif; 2015 Jul; 111():18-22. PubMed ID: 25795130
[TBL] [Abstract][Full Text] [Related]
16. Improved production of single domain antibodies with two disulfide bonds by co-expression of chaperone proteins in the Escherichia coli periplasm.
Shriver-Lake LC; Goldman ER; Zabetakis D; Anderson GP
J Immunol Methods; 2017 Apr; 443():64-67. PubMed ID: 28131818
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C
Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809
[TBL] [Abstract][Full Text] [Related]
18. Selective and efficient extraction of recombinant proteins from the periplasm of Escherichia coli using low concentrations of chemicals.
Jalalirad R
J Ind Microbiol Biotechnol; 2013 Oct; 40(10):1117-29. PubMed ID: 23864192
[TBL] [Abstract][Full Text] [Related]
19. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
Ahmadvand D; Rahbarizadeh F; Vishteh VK
Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
